Clinical trials · Washington, D.C., DC
Hepatitis C clinical trials in Washington, D.C.
We’re tracking 4 recruiting hepatitis c studies with a site in or near Washington, D.C. — including Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Washington, D.C.
- NCT00001971Recruiting
Evaluation of patients with liver disease
This research study evaluates people with liver disease or at risk for liver disease, and compares them with healthy volunteers. The goal is to better understand liver disease and improve how doctors diagnose and treat it.
Bethesda, MarylandAges 2–100 - NCT04162938Recruiting
Tablet app to help emergency patients learn about hepatitis C
This trial tests whether a patient-friendly electronic app given in the emergency department can increase what you know about hepatitis C and help you move to the next steps of care. It may be most helpful for people who are hepatitis C–positive but don’t yet have clear information about their status.
Baltimore, MarylandAges 18–100 - NCT07040319RecruitingPhase 1/Phase 2
Hepatitis C treatment study for pregnant women
This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.
Baltimore, MarylandAges 16–45 - NCT07317687Recruiting
Rapid HIV, Hep C, and Syphilis Testing in Street Medicine
This trial offers free rapid testing for HIV, hepatitis C, and syphilis during street medicine visits. It helps find infections early so you can get connected to care.
Harpers Ferry, West VirginiaAges 18 years+
Hear when a new Hepatitis C trial opens near Washington, D.C., DC
We’ll email you when one opens near Washington, D.C., DC — at most once a week, no account needed, unsubscribe anytime.
Hepatitis C trials in other cities
Where these studies are running near Washington, D.C.
Institutions with a site for the recruiting hepatitis c studies listed above.
- Johns Hopkins University · 2 studies
- National Institutes of Health Clinical Center
- WVU Department of Family Medicine - Eastern Division
What taking part in a hepatitis c study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there hepatitis c clinical trials near Washington, D.C.?
- Yes. We're currently tracking 4 recruiting hepatitis c studies with a site near Washington, D.C., each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hepatitis c study near Washington, D.C.?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Washington, D.C. to take part?
- Not necessarily. These studies have a site near Washington, D.C., but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hepatitis c trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hepatitis c studies open near Washington, D.C. regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.